Cardiovascular Diseases

Function-Guided Complete Revascularization Improves Outcomes in STEMI

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete coronary revascularization guided by functional coronary angiography significantly reduced both major cardiovascular events and key safety events compared with conventional angiography-guided treatment. In this international randomized trial, 1,823 patients whose culprit lesion had been successfully treated were assigned to function-guided or conventional angiography-guided complete revascularization. The primary composite outcome of death from any cause, myocardial infarction, cerebrovascular events, or ischemia-driven revascularization occurred in 8.9% of the function-guided group versus 13.7% of the angiography-guided group at a median follow-up of 17.9 months (hazard ratio [HR], 0.62). The primary safety outcome, a composite of contrast-associated acute kidney injury or major bleeding, also occurred less frequently with functional guidance (4.6% vs. 7.1%; HR, 0.63). These findings indicate that, among patients with STEMI and multivessel disease, using functional coronary angiography to guide complete revascularization provides better clinical outcomes than relying on conventional angiography alone. Source: https://www.nejm.org/

hyangiu

Recent Posts

2026 Fifth Universal Definition of Myocardial Infarction

The Fifth Universal Definition of Myocardial Infarction (MI) updates the classification of MI by defining…

2 hours ago

Updated US Guideline on Pharmacologic Prevention of Migraine in Adults

The US updated evidence-based recommendations provide clinicians with comprehensive guidance on when to initiate pharmacologic…

7 hours ago

Catheter-Directed Thrombolysis Improves Outcomes in Intermediate-High–Risk Pulmonary Embolism

In patients with intermediate-high–risk acute pulmonary embolism, catheter-directed thrombolysis with alteplase plus anticoagulation significantly reduced…

1 day ago

Atorvastatin Prevents Cardiovascular Events in Older Adults without Prior Cardiovascular Disease

In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by…

3 days ago

Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HCM

In patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), aficamten significantly improved exercise capacity and patient-reported…

4 days ago

DOACs Reduce Cardiovascular Events in Atrial Fibrillation at Intermediate Stroke Risk

In patients with atrial fibrillation at intermediate risk for stroke, direct oral anticoagulant (DOAC) therapy…

4 days ago

This website uses cookies.